Q1 2025 Holdings
Filed 2025-05-15 | 39 holdings | $562.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $57.3M | 3,500,000 | 10.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $56.6M | 1,600,000 | 10.1% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $48.6M | 1,200,000 | 8.6% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $44.6M | 1,650,000 | 7.9% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $35.5M | 500,000 | 6.3% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $26.1M | 1,700,000 | 4.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $21.8M | 650,000 | 3.9% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $20.4M | 2,000,000 | 3.6% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $19.6M | 394,342 | 3.5% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $18.2M | 200,000 | 3.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $18.2M | 2,500,000 | 3.2% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $17.9M | 250,000 | 3.2% |
| Erasca Inc(ERAS) | COM | 29479A108 | $17.8M | 13,000,000 | 3.2% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $16.9M | 2,300,000 | 3.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $16.3M | 4,217,627 | 2.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $13.7M | 350,000 | 2.4% |
| Geron Corp(GERN) | COM | 374163103 | $12.7M | 8,000,000 | 2.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $12.1M | 3,208,875 | 2.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $11.7M | 350,000 | 2.1% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $10.3M | 350,000 | 1.8% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $10.3M | 936,914 | 1.8% |
| Annexon Inc(ANNX) | COM | 03589W102 | $7.7M | 4,000,000 | 1.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.4M | 425,000 | 1.3% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $5.7M | 2,000,000 | 1.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $5.2M | 500,000 | 0.9% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.7M | 240,000 | 0.8% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $4.7M | 275,000 | 0.8% |
| Aerovate Therapeutics Inc | COM | 008064107 | $3.5M | 1,400,000 | 0.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $3.4M | 2,222,222 | 0.6% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $2.9M | 5,078,927 | 0.5% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $2.7M | 424,715 | 0.5% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $2.7M | 500,000 | 0.5% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $2.1M | 208,910 | 0.4% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $1.1M | 5,400,000 | 0.2% |
| Septerna Inc(SEPN) | COM | 81734D104 | $777.0K | 134,202 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $660.0K | 2,900,000 | 0.1% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $435.3K | 145,089 | 0.1% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $370.0K | 100,000 | 0.1% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $15.9K | 66,666 | 0.0% |